Cancer Cells Hijack Physiologic Metabolic Signals to Seed Liver Metastasis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 38502849.
- Also identified by DOI 10.1158/0008-5472.CAN-24-0835 and PMC identifier 11157585.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Metastasis arises from cancer cell-intrinsic adaptations and permissive tumor microenvironments (TME) that are distinct across different organs. Deciphering the mechanisms underpinning organotropism could provide novel preventive and therapeutic strategies for patients with cancer. Rogava and colleagues identified Pip4k2c as a driver of liver metastasis, acting by sensitizing cancer cells to insulin-dependent PI3K/AKT signaling, which could be reversed by dual pharmacologic inhibition of PI3K and SGLT2 or a ketogenic diet. The study highlights the importance of tumor microenvironment communication in the context of systemic physiology and points toward potential combination therapies.
Medical subject headings
- Liver Neoplasms
- Tumor Microenvironment
- Signal Transduction